Abraham Chachoua

Biosketch / Results /

Abraham Chachoua, M.D.

Jay and Isabel Fine Associate Professor of Oncology; Associate Professor; Assoc Dir Cancer Services Perlmutter Cancer Center; Service Chief at NYUHC; Co Director Thoracic Onc Research Prog
Departments of Medicine (Perlmutter Cancer Center) and Urology (Administration)
NYU Medical Oncology Associates

Clinical Addresses

160 EAST 34 STREET, 2 FLOOR
NEW YORK, NY 10016
Hours: Mon. 9 - 5; Tue. 9 - 5; Thu. 9 - 5; Fri. 9 - 5
Handicap Access: yes
Phone: 212-731-5388
Fax: 212-731-5545

« Back to Results

Medical Specialties

Cancer, Medical Oncology

Medical Expertise

Kidney Cancer, Lung Cancer, Testicular Cancer, Bladder Cancer

Clinical Responsibilities

Dr. Chachoua started the multidisciplinary lung conference which now meets weekly, where all patients are discussed and management decisions are made based on the input of experts from multiple fields including surgery, radiation oncology, pulmonary and radiology.

Member of Eastern Cooperative Oncology Group.

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, AFFINITY EXCHANGE- ESSENTIAL, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, FIDELIS CHLD HLTH, FIDELIS EXCHANGE, FIDELIS FAM HLTH, FIDELIS MEDICARE, Fidelis Medicaid, GHI CBP, HEALTHPLUS CHLD HLTH (AMERIGROUP), HEALTHPLUS FAM HLTH (AMERIGROUP), HEALTHPLUS MEDICAID (AMERIGROUP), HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, METROPLUS CHLD HLTH, METROPLUS EXCHANGE PLANS, METROPLUS FAM HLTH, MULTIPLAN/PHCS PPO, Medicare, MetroPlus Medicaid, NYS EMPIRE PLAN, OSCAR, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, Tricare UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS, UPN Elite, WELLCARE CHLD HLTH, WELLCARE FAM HLTH, WELLCARE MEDICAID, WELLCARE MEDICARE

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Education

1980-1982 — Alfred Hospital (Rotating), Residency Training
1983-1984 — Alfred Hospital (Hematology/Oncology), Clinical Fellowships

« Back to Results

Research Summary

Dr. Abraham Chachoua specializes in the treatment of thoracic malignancies. Originally trained in Melbourne, Australia, he came to NYU to complete a research fellowship in medical oncology and was the recipient of an American Cancer Society career development award to evaluate the role of immune modulation in the treatment of solid tumors.

He has been involved in a number of clinical trials for the treatment of non small cell lung cancer.

Dr. Chachoua has a particular interest in the study of novel targeted therapies, how to use them earlier in the course of the illness and how to combine them with conventional chemotherapy for the treatment of advanced thoracic cancers. Among other interests he also attempts to use unique approaches for the integration of multimodality approaches for the treatment of locally advanced lung cancer.

Research Interests

Studies in monocyte function and activation.

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Reflex Testing of Small Biopsy Specimens for EGFR and ALK Is Practical and Facilitates Implementation of the 2013 CAP/IASLC/AMP Guidelines for Lung Cancer Biomarker Testing in Patients with Advanced Stage Disease
Krausert, A.; Sirdhar, D.; Pass, H.; Chachoua, A.; Suh, J.
2014 FEB;27 2 2:483A-483A, Modern pathology
— id: 855492, year: 2014, vol: 27 2 2, page: 483A, stat: Journal Article,

Reflex Testing of Small Biopsy Specimens for EGFR and ALK Is Practical and Facilitates Implementation of the 2013 CAP/IASLC/AMP Guidelines for Lung Cancer Biomarker Testing in Patients with Advanced Stage Disease
Krausert, A.; Sridhar, D.; Pass, H.; Chachoua, A.; Suh, J.
2014 FEB;94 1 1:483A-483A, Laboratory investigation
— id: 855352, year: 2014, vol: 94 1 1, page: 483A, stat: Journal Article,

Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer
Belani, Chandra P; Nemunaitis, John J; Chachoua, Abraham; Eisenberg, Peter D; Raez, Luiz E; Cuevas, J Daniel; Mather, Cecile B; Benner, Rebecca J; Meech, Sandra J
2013 Jul;14(7):557-563, Cancer biology & therapy
— id: 516362, year: 2013, vol: 14, page: 557, stat: Journal Article,

An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Golden, Encouse B; Demaria, Sandra; Schiff, Peter B; Chachoua, Abraham; Formenti, Silvia C
2013 Dec;1(6):365-372, Cancer immunology research
— id: 845732, year: 2013, vol: 1, page: 365, stat: Journal Article,

Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?
Marquez-Medina, D; Chachoua, A; Martin-Marco, A; Desai, A M; Garcia-Reglero, V; Salud-Salvia, A; Muggia, F
2013 Nov;15(11):959-964, Clinical & translational oncology
— id: 611782, year: 2013, vol: 15, page: 959, stat: Journal Article,

Plasma osteopontin and the prognosis of pleural mesothelioma
Pass, H I; Donington, J S; Gadgeel, S M; Chachoua, A; Wozniak, A J; Liu, G; Tsao, M S; De, Perrot M; Goparaju, C
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 451842, year: 2013, vol: 31, page: , stat: Journal Article,

CT Scan Screening for Lung Cancer: Risk Factors for Nodules and Malignancy in a High-Risk Urban Cohort
Greenberg, Alissa K; Lu, Feng; Goldberg, Judith D; Eylers, Ellen; Tsay, Jun-Chieh; Yie, Ting-An; Naidich, David; McGuinness, Georgeann; Pass, Harvey; Tchou-Wong, Kam-Meng; Addrizzo-Harris, Doreen; Chachoua, Abraham; Crawford, Bernard; Rom, William N
2012 ;7(7):e39403-e39403 e39403, PLoS ONE
— id: 171565, year: 2012, vol: 7, page: e39403, stat: Journal Article,

Kras Mutations And Outcomes For Patients With Stage IV NSCLC Treated With Frontline Platinum/Pemetrexed Based Chemotherapy
Levy, B.; Seetharamu, N.; Richardson, S.; Becker, D.; Chachoua, A.
2012 SEP;7(9 4 4):S248-S248, Journal of thoracic oncology
— id: 306472, year: 2012, vol: 7, page: S248, stat: Journal Article,

SALVAGE RADIOTHERAPY FOR SOLITARY FOCUS OF DISEASE PROGRESSION COULD ALLOW MAINTAINING THE EFFICACY OF ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER
Marquez-Medina, Diego; Chachoua, Abraham; Gasol Cudos, Ariadna; Muggia, Franco
2012 JUL;7(7):S119-S119, Journal of thoracic oncology
— id: 174424, year: 2012, vol: 7, page: S119, stat: Journal Article,

Long-term Follow-up of a Prospective Phase I-II Study of Concurrent Paclitaxel and Radiation Therapy With Hormonal Ablation in Locally Advanced Prostate Cancer
Sanfilippo, N. J.; Taneja, S. S.; Chachoua, A.; Lepor, H.; Formenti, S. C.
2012 NOV 1;84(3 S S):S92-S92, International journal of radiation oncology biology physics
— id: 204882, year: 2012, vol: 84, page: S92, stat: Journal Article,

The management of EGFR inhibitor adverse events: a case series and treatment paradigm
Wnorowski, Amelia M; de Souza, Aieska; Chachoua, Abraham; Cohen, David E
2012 Feb;51(2):223-232, International journal of dermatology
— id: 149965, year: 2012, vol: 51, page: 223, stat: Journal Article,

Increasing dyspnea due to an anterior mediastinal mass
Alpert, Jeffrey B; Nonaka, Daisuke; Chachoua, Abraham; Pass, Harvey I; Ko, Jane P
2011 Jan;139(1):217-223, Chest
— id: 117359, year: 2011, vol: 139, page: 217, stat: Journal Article,

Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
Ballas, Marc S; Chachoua, Abraham
2011 ;4:43-58, OncoTargets & therapy
— id: 134470, year: 2011, vol: 4, page: 43, stat: Journal Article,

RANDOMIZED PHASE II TRIAL OF ERLOTINIB WITH OR WITHOUT PF-3512676 (CPG 7909, A TOLL-LIKE RECEPTOR 9 [TLR9] AGONIST) IN PATIENTS WITH ADVANCED RECURRENT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
Belani, Chandra P.; Nemunaitis, John J.; Chachoua, Abraham; Eisenberg, Peter D.; Raez, Luis E.; Cuevas, Juan D.; Mather, Cecile B.; Benner, Rebecca J.; Meech, Sandra J.
2011 JUN ;6(6):S1218-S1219, Journal of thoracic oncology
— id: 134900, year: 2011, vol: 6, page: S1218, stat: Journal Article,

Lung sparing maximal cytoreduction for pleural mesothelioma compares favorably with extrapleural pneumonectomy
Pass, H I; Gadgeel, S; Wozniak, A; Chachoua, A
2011 June 2011;6(6):S487-S488, Journal of thoracic oncology
— id: 668952, year: 2011, vol: 6, page: S487, stat: Journal Article,

The appearance of cardiac metastasis from squamous cell carcinoma of the lung on F-18 FDG PET/CT and post hoc PET/MRI
Probst, Stephan; Seltzer, Alexandra; Spieler, Bradley; Chachoua, Abraham; Friedman, Kent
2011 Apr;36(4):311-312, Clinical nuclear medicine
— id: 134122, year: 2011, vol: 36, page: 311, stat: Journal Article,

RRM-1 IS PREDICTIVE OF CLINICAL BENEFIT FROM FIRST LINE PLATINUM DOUBLET THERAPY IN NON-SMALL CELL LUNG CANCER
Seetharamu, Nagashree; Pass, Harvey I.; Levinson, Benjamin; Ballas, Marc; Musovic, Sabina; Metz, Michael; Mathew, Lynn; Sorensen, Audrey; Chachoua, Abraham
2011 JUN ;6(6):S995-S996, Journal of thoracic oncology
— id: 134899, year: 2011, vol: 6, page: S995, stat: Journal Article,

Azygos venous tumor thrombus from renal cell carcinoma detected by F-18 FDG PET/CT
Probst, Stephan; Seltzer, Alexandra; Chachoua, Abraham; Friedman, Kent
2010 Oct;35(10):832-833, Clinical nuclear medicine
— id: 162478, year: 2010, vol: 35, page: 832, stat: Journal Article,

Sequential and intermittent docetaxel (D) and imatinib (Im) in hormone-refractory prostate cancer patients (NYU 04-47)
Gmez-Pinillos A.; Ballard H.; Shelton G.; Reilly M.M.; Chachoua A.; Taneja S.; Ferrari A.C.
2009 ;27(15 Suppl 1):?-? #e16108, Journal of clinical oncology
— id: 111804, year: 2009, vol: 27, page: ?, stat: Journal Article,

Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer
Sanfilippo, Nicholas J; Taneja, Samir S; Chachoua, Abraham; Lepor, Herbert; Formenti, Silvia C
2008 Jun 20;26(18):2973-2978, Journal of clinical oncology
— id: 79569, year: 2008, vol: 26, page: 2973, stat: Journal Article,

IMRT treatment for locally advanced non-small cell lung cancer achieves low levels of pulmonary irradiation including the low-dose volume, V 5 Gy, along with low levels of esophageal and cardiac irradiation
Chandra, A; Mitchell, JD; McCarthy, A; Chachoua, A; Jozsef, G; DeWyngaert, K; Pass, HI; Formenti, S
2007 JAN ;69(3):S523-S523, International journal of radiation oncology biology physics
— id: 87195, year: 2007, vol: 69, page: S523, stat: Journal Article,

Phase I study of bi-weekly paclitasel and definitive radiation in androgen ablated locally advanced prostate cancer
Sanfilippo, NJ; Taneja, SS; Chachoua, A; Lepor, H; Formenti, SC
2007 JAN ;69(3):S112-S113, International journal of radiation oncology biology physics
— id: 87193, year: 2007, vol: 69, page: S112, stat: Journal Article,

Phase I dose-escalating study of bi-weekly pemetrexed (MTA) with fixed dose rate gemcitabine (gem) in patients with advanced cancer
Chen, AL; Ryan, T; Muggia, F; Chachoua, A; Escalon, J; Moore, S; Haniff, F; Levinson, B; Nicol, S; Hochster, H
2006 JUN 20 ;24(18):91S-91S, Journal of clinical oncology
— id: 69296, year: 2006, vol: 24, page: 91S, stat: Journal Article,

A phase I study of continuous intravenous infusion (CIV) low-dose topotecan (T) combined with thoracic radiotherapy (RT)
Chandra, A; Chang, R; Steinfeld, A; Chachoua, A; Muggia, F; Formenti, S; Hochster, H
2005 ;63(2):2314-2314, International journal of radiation oncology biology physics
— id: 109248, year: 2005, vol: 63, page: 2314, stat: Journal Article,

Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle
Hamilton, A L; Eder, J P; Pavlick, A C; Clark, J W; Liebes, L; Garcia-Carbonero, R; Chachoua, A; Ryan, D P; Soma, V; Farrell, K; Kinchla, N; Boyden, J; Yee, H; Zeleniuch-Jacquotte, A; Wright, J; Elliott, P; Adams, J; Muggia, F M
2005 Sep 1;23(25):6107-6116, Journal of clinical oncology
— id: 57888, year: 2005, vol: 23, page: 6107, stat: Journal Article,

A phase I study of carboplatin plus oral topotecan in advanced malignancies
Kim, E; Hochster, H; Novik, Y; Chachoua, A; Speyer, J; Muggia, F
2004 JUL 15 ;22(14):161S-161S, Journal of clinical oncology
— id: 48677, year: 2004, vol: 22, page: 161S, stat: Journal Article,

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer
Perez-Soler, Roman; Chachoua, Abraham; Hammond, Lisa A; Rowinsky, Eric K; Huberman, Mark; Karp, Daniel; Rigas, James; Clark, Gary M; Santabarbara, Pedro; Bonomi, Philip
2004 Aug 15;22(16):3238-3247, Journal of clinical oncology
— id: 44862, year: 2004, vol: 22, page: 3238, stat: Journal Article,

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer
Hochster, Howard; Chachoua, Abraham; Speyer, James; Escalon, Juliette; Zeleniuch-Jacquotte, Anne; Muggia, Franco
2003 Jul 15;21(14):2703-2707, Journal of clinical oncology
— id: 44743, year: 2003, vol: 21, page: 2703, stat: Journal Article,

A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting
Sewak, Sanjeev; Chachoua, Abraham; Hamilton, Anne; Taneja, Samir; Lee, Janet; Utate, Minerva; Sorich, Joan; Muggia, Franco M
2003 Jan;14(1):67-72, Anti-cancer drugs
— id: 34609, year: 2003, vol: 14, page: 67, stat: Journal Article,

TIA-1+ cytotoxic large T-cell lymphoma of the mediastinum: Case report
Yang, Grace C H; Yee, Herman T; Wu, C Daniel; Aye, Lwin M; Chachoua, Abraham
2002 Mar;26(3):154-157, Diagnostic cytopathology
— id: 27219, year: 2002, vol: 26, page: 154, stat: Journal Article,

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma
Ferrari AC; Chachoua A; Singh H; Rosenthal M; Taneja S; Bednar M; Mandeli J; Muggia F
2001 Jun 1;91(11):2039-2045, Cancer
— id: 34610, year: 2001, vol: 91, page: 2039, stat: Journal Article,

A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer
Ko YJ; Small EJ; Kabbinavar F; Chachoua A; Taneja S; Reese D; DePaoli A; Hannah A; Balk SP; Bubley GJ
2001 Apr;7(4):800-805, Clinical cancer research
— id: 34611, year: 2001, vol: 7, page: 800, stat: Journal Article,

A phase II trial of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), CP-358,774, following platinum-based chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Bonomi, P; Perez-Soler, R; Chachoua, A; Huberman, M; Karp, D; Rigas, J; Hammond, L; Rowinsky, E; Preston, G; Ferrente, KJ; Allen, LF
2000 NOV ;6(6):4544S-4544S, Clinical cancer research
— id: 54443, year: 2000, vol: 6, page: 4544S, stat: Journal Article,

Proteasome inhibition by PS-341: A phase I study
Hamilton, A; Eder, JP; Pavlick, A; Clark, JW; Chachoua, A; Ryan, DP; Farrell, K; Wasserstrom, H; Liebes, L; Wright, J; Elliott, P; Adams, J; Muggia, F
2000 NOV ;6(6):4549S-4549S, Clinical cancer research
— id: 54445, year: 2000, vol: 6, page: 4549S, stat: Journal Article,

Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial - The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group
Lewis, RA; Carr, LM; Doyle, K; Fainstein, V; Gross, R; Orengo-Nania, S; Samo, TC; Shigley, JW; Spencer, SS; Weinert, M; Dunn, JP; Bartlett, J; Becker, R; Feinberg, J; Jabs, DA; Johnson, DA; LaSalvia, S; Miller, T; Neisser, LG; Semba, RD; Tay-Kearney, ML; Tucker, P; Barron, B; Jarrott, C; Peyman, G; Swenie, D; Friedman, AH; Ginsburg, R; Sacks, H; Severin, C; Teich, S; Wallach, F; Rescigno, R; Cowan, J; Horan, C; Kloser, P; Wanner, M; Friedberg, DN; Addessi, A; Chachoua, A; Dieterich, D; Hill, J; Hutt, R; Ligh, J; Lorenzo-Latkany, M; Pei, M; Powers, T; Scoppe, C; Weinberg, DV; Jampol, LM; Lyon, AT; Munana, A; Murphy, R; Palella, F; Richine, L; Strugala, Z; Valadez, G; Holland, GN; Carlson, ME; Chafey, S; Hardy, WD; Johiro, AK; MacArthur-Chang, LJ; Martin, MA; Moe, AA; Strong, CA; Tufail, A; Ugalat, PS; Weisz, JM; Freeman, WR; Arevalo-Colina, JF; Clark, T; Jarman, CL; Meixner, L; Meng, TC; Spector, S; Taskintuna, I; Torriani, FJ; O'Donnell, J; Alfred, P; Ballesteros, F; Clay, D; Coleman, R; Gordon, K; Gumbley, D; Hoffman, J; Irvine, A; Jacobson, M; Larson, J; Macalalag, L; Narahara, M; Payne, M; Seiff, S; Wilson, S; Woodring, H; Davis, J; Mendez, P; Murray, T; Simmons, T; van der Horst, C; Kylstra, J; Wohl, D; Ziman, K; Pavan, PR; Bergen, GA; Cohen, SM; Craig, JA; Dehler, RL; Elbert, E; Fox, RW; Grizzard, WS; Hammer, ME; Hernandez, LS; Herrera, S; Holt, D; Kemp, S; Larkin, JA; Ledford, DK; Lockey, RF; Menosky, MM; Millard, S; Nadler, JP; Nelson, RP; Norris, D; Ormerod, LD; Pautler, SE; Poblete, SJ; Rodriguez, D; Rosenbach, KP; Seekins, DW; Toney, JR; Jabs, DA; Dodge, JM; Klemstine, JL; Schuerholtz, TA; Stevens, M; Meinert, CL; Amend-Libercci, D; Coleson, L; Collins, KL; Collison, BJ; Dawson, C; Dodge, J; Donithan, M; Ewing, C; Fink, N; Gerczak, C; Harle, J; Holbrook, JT; Huffman, R; Isaacson, MR; Gilpin, AMK; Lane, M; Levine, CR; Martin, B; Meinert, J; Nowakowski, DJ; Owens, RM; Piantadosi, B; Saah, A; Smith, M; Tonascia, J; Van Natta, ML; Davis, MD; Armstrong, J; Brickbauer, J; Brothers, R; Chop, M; Hubbard, L; Hurlburt, D; Kastorff, L; Magli, Y; Neider, M; Onofrey, J; Stoppenbach, V; Vanderhoof-Young, M; Walls, M; Hughes, R; Kurinij, N; Mowery, RL; Alston, B; Foulkes, M; Jabs, DA; Davis, MD; Kurinij, N; Meinert, CL; Mowery, RL; Jabs, DA; Addessi, A; Alston, B; Clark, T; Davis, MD; Feinberg, J; Freeman, W; Holbrook, J; Holland, GN; Hubbard, L; Jacobson, M; Kurinij, N; Lewis, RA; McArthur-Chang, L; Meinert, C; Mowery, R; Murphy, R; Polsky, B; Tonascia, J; Jabs, DA; Davis, MD; Duncan, WR; Feinberg, J; Kessler, H; Kurinij, N; Lambert, AG; Meinert, CL; Mowery, RL; Powderly, W; Schnittman, S; Spector, S; Tonascia, J; Brown, BW; Conway, B; Grizzle, J; Nussenblatt, R; Phair, JP; Smith, H; Whitley, R; Alston, B; Davis, MD; Foulkes, M; Jabs, DA; Kurinij, N; Meinert, CL; Mowery, RL; Tonascia, J; Jabs, DA; Freeman, WR; Jacobson, M; Murphy, R; Van Natta, ML; Meinert, CL; Cheng, B; Frost, K; Lambert, AG; Marco, M
2000 JUL 28 ;14(11):1571-1581, AIDS
— id: 54539, year: 2000, vol: 14, page: 1571, stat: Journal Article,

Thirty day multiple dose administration of PEI
Llebes, L; Hochster, H; Conaway, CC; Chachoua, A; Farrell, K; Lee, J; Mendoza, S; Crowell, J; Carmella, C; Murphy, S; Hecht, SS; Chung, F
2000 NOV ;6(6):4486S-4487S, Clinical cancer research
— id: 54439, year: 2000, vol: 6, page: 4486S, stat: Journal Article,

Prostatic adenocarcinoma metastatic to the breasts: report of a case with diagnosis by fine needle aspiration biopsy
Yan Z; Hummel P; Waisman J; Newstead GM; Chachoua A; Chhieng D; Cohen JM; Cangiarella J
2000 Apr;55(4):590-590, Urology
— id: 11767, year: 2000, vol: 55, page: 590, stat: Journal Article,

Inhibition of angiogenesis and matrix metalloproteinase-2 activity by dexrazoxane (zinecard) may mediate its antitumor effects
Chuang JN; Ren CJ; Mendoza S; Shamamian P; Roses DF; Rifkin DB; Chachoua A; Shapiro RL
1998 ;49:424-426, Surgical forum
— id: 25210, year: 1998, vol: 49, page: 424, stat: Journal Article,

Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignancies
Rosenthal MA; Dennis D; Liebes L; Furmanski P; Caron D; Garrison L; Wiprovnick J; Peace D; Oratz R; Speyer J; Chachoua A
1998 Sep;21(5):371-378, Journal of immunotherapy
— id: 7436, year: 1998, vol: 21, page: 371, stat: Journal Article,

Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin
Gottlieb JJ; Washenik K; Chachoua A; Friedman-Kien A
1997 Nov 8;350(9088):1363-1364, Lancet
— id: 10106, year: 1997, vol: 350, page: 1363, stat: Journal Article,

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study
Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Blum RH; Zeleniuch-Jacquotte A
1997 Aug;3(8):1245-1252, Clinical cancer research
— id: 56951, year: 1997, vol: 3, page: 1245, stat: Journal Article,

Parenteral cidofovir for cytomegalovirus retinitis in patients with AI
Lewis, RA; Carr, LM; Doyle, K; Fainstein, V; Gross, R; OrengoNania, S; Samo, TC; Shigley, JW; Spencer, SS; Weinert, M; Dunn, JP; Bartlett, J; Becker, R; Feinberg, J; Jabs, DA; Johnson, DA; LaSalvia, S; Miller, T; Neisser, LG; Semba, RD; TayKearney, ML; Tucker, P; Barron, B; Jarrott, C; Peyman, G; Swenie, D; Friedman, AH; Ginsburg, R; Sacks, H; Severin, C; Teich, S; Wallach, F; Rescigno, R; Cowan, J; Horan, C; Kloser, P; Wanner, M; Friedberg, DN; Addessi, A; Chachoua, A; Dieterich, D; Hill, J; Hutt, R; Ligh, J; LorenzoLatkany, M; Pei, M; Powers, T; Scoppe, C; Weinberg, DV; Jampol, LM; Lyon, AT; Munana, A; Murphy, R; Palella, F; Richine, L; Strugala, Z; Valadez, G; Holland, GN; Carlson, ME; Chafey, S; Hardy, WD; Johiro, AK; MacarthurChang, L; Martin, MA; Moe, AA; Strong, CA; Tufail, A; Ugalat, PS; Weisz, JM; Freeman, WR; ArevaloColina, JF; Clark, T; Jarman, CL; Meixner, L; Meng, TC; Spector, S; Taskintuna, I; Torriani, FJ; ODonnell, J; Alfred, P; Ballesteros, F; Clay, D; Coleman, R; Gumbley, D; Hoffman, J; Irvine, A; Jacobson, M; Larson, J; Macalalag, L; Narahara, M; Payne, M; Seiff, S; Wilson, S; Woodring, H; Davis, J; Mendez, P; Murray, T; Simmons, T; vanderHorst, C; Kylstra, J; Wohl, D; Ziman, K; Pavan, PR; Bergen, GA; Cohen, SM; Craig, JA; Dehler, RL; Elbert, E; Fox, RW; Grizzard, WS; Hammer, ME; Hernandez, LS; Herrera, S; Holt, D; Kemp, S; Larkin, JA; Ledford, DK; Lockey, RF; Menosky, MM; Millard, S; Nadler, JP; Nelson, RP; Norris, D; Ormerod, LD; Pautler, SE; Poblete, SJ; Rodriguez, D; Rosenbach, KP; Seekins, DW; Toney, JR; Dodge, JM; Klemstine, JL; Schuerholtz, TA; Stevens, M; Meinert, CL; AmendLibercci, D; Coleson, L; Collins, KL; Collison, BJ; Dawson, C; Dodge, J; Donithan, M; Ewing, C; Fink, N; Gerczak, C; Harle, J; Holbrook, JT; Huffman, R; Isaacson, MR; Gilpin, AMK; Lane, M; Levine, CR; Martin, B; Meinert, J; Nowakowski, DJ; Owens, RM; Piantadosi, B; Saah, A; Smith, M; Tonascia, J; VanNatta, ML; Davis, MD; Armstrong, J; Brickbauer, J; Brothers, R; Chop, M; Hubbard, L; Hurlburt, D; Kastorff, L; Magli, Y; Neider, M; Onofrey, J; Stoppenbach, V; VanderhoofYoung, M; Walls, M; Hughes, R; Kurinij, N; Mowery, RL; Alston, B; Foulkes, M; Freeman, W; Holbrook, J; Meinert, C; Mowery, R; Polsky, B; Duncan, WR; Kessler, H; Lambert, AG; Powderly, W; Schnittman, S; Spector, S; Brown, BW; Conway, B; Grizzle, J; Nussenblatt, R; Phair, JP; Smith, H; Whitley, R; Cheng, B; Frost, K; Marco, M
1997 FEB 15 ;126(4):264-&, Annals of internal medicine
— id: 53289, year: 1997, vol: 126, page: 264, stat: Journal Article,

MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency in syndrome - The monoclonal antibody cytomegalovirus retinitis trial
Lewis, RA; CarrHolden, LM; Doyle, K; Fainstein, V; Gardner, N; Gross, R; OrengoNania, S; Patel, V; Samo, TC; Shigley, JW; Shawver, L; Spencer, SS; Weinert, M; Martin, DF; Gibbs, D; Jernigan, J; Dunn, JP; Bartlett, J; Becker, R; Jabs, DA; Johnson, DA; LaSalvia, S; Leslie, J; Maenza, J; Miller, T; Neisser, LG; Semba, RD; Tucker, P; Barron, B; Jarrott, C; Peyman, G; Swenie, D; Heinemann, MH; Janis, R; Polsky, B; Sepkowitz, K; Friedman, AH; Ginsburg, R; Severin, C; Teich, S; Wallach, F; Rescigno, R; PaezBoham, R; Buroff, E; Kloser, P; Wanner, M; Friedberg, DN; Addessi, A; Chachoua, A; Dieterich, D; Hill, J; Hutt, R; Kaul, A; Ligh, J; LorenzoLatkany, M; Pei, M; Powers, T; Weinberg, DV; Jampol, EM; Lyon, AT; Munana, A; Murphy, R; Palella, F; Richine, L; Strugala, Z; Valadez, G; Holland, GN; Carlson, ME; Chafey, SA; Hardy, WD; Johiro, AK; MacArthurChang, LJ; Martin, MA; Moe, AA; Strong, CA; Tufail, A; Ugalat, PS; Weisz, JM; Freeman, WR; ArevaloColina, JF; Clark, T; Jarman, CL; Meixner, L; Meng, TC; Spector, S; Taskintuna, I; Torriani, FJ; ODonnell, J; Alfred, P; Ballesteros, F; Clay, D; Coleman, R; Gordon, K; Gumbley, D; Hoffman, J; Irvine, A; Jacobson, M; Larson, M; Macalalag, L; Narahara, M; Payne, M; Seiff, S; Wilson, S; Woodring, H; Davis, J; Blenke, A; Madera, I; Mendez, P; Murray, T; vanderHorst, C; Kylstra, J; Wohl, D; Ziman, K; Pavan, PR; Grizzard, WS; Bergen, GA; Cohen, SM; Craig, JA; Dehler, RL; Elbert, E; Fox, RW; Hammer, ME; Hernandez, LS; Herrera, S; Holt, D; Kemp, S; Larkin, JA; Ledford, DK; Lockey, RF; Menosky, MM; Millard, S; Nadler, JP; Nelson, RP; Norris, D; Ormerod, LD; Pautler, SE; Poblete, SJ; Rodriguez, D; Rosenbach, KP; Seekins, DW; Toney, JR; Dodge, JM; Klemstine, JL; Schuerholtz, TA; Stevens, M; Meinert, CL; AmendLibercci, D; Coleson, L; Collins, KL; Collison, BJ; Dawson, C; Dodge, J; Donithan, M; Ewing, C; Fink, N; Gerczak, C; Harle, J; Holbrook, JT; Huffman, R; Isaacson, MR; Gilpin, AMK; Lane, M; Levine, CR; Martin, B; Meinert, J; Min, N; Nowakowski, DJ; Owens, RM; Oziemkowska, MJ; Piantadosi, B; Saah, A; Smith, M; Tonascia, J; VanNatta, ML; Davis, MD; Armstrong, J; Brickbauer, J; Brothers, R; Chop, M; Hubbard, L; Hurlburt, D; Kastorff, L; Neider, M; Onofrey, J; Stoppenbach, V; VanderhoofYoung, M; Walls, M; Hughes, R; Kurinij, N; Mowery, RL; Alston, B; Foulkes, M; Nadler, PI; Wood, DL; Bladet, M; Wu, N; Clark, T; Feinberg, J; Freeman, W; Holbrook, J; McArthurChang, L; Duncan, WR; Kessler, H; Lambert, AG; Powderly, W; Schnittman, S; Spector, S; Brown, BW; Conway, B; Grizzle, J; Nussenblatt, R; Phair, JP; Smith, H; Whitley, R; Cheng, B; Frost, K; Marco, M
1997 DEC ;115(12):1528-1536, Archives of ophthalmology (1960)
— id: 53126, year: 1997, vol: 115, page: 1528, stat: Journal Article,

Phase II study of topotecan (TPT) 21-day infusion in platinum-treated ovarian cancer: a highly active regimen (A NYGOG study)
Hochster H; Speyer J; Wadler S; Runowicz C; Wallach R; Oratz R; Chachoua A; Sorich J; Taubes B; Ludwig E; Broom C; Blum R
1996 ;15:A775-A775, Proceedings (American Society of Clinical Oncology)
— id: 6025, year: 1996, vol: 15, page: A775, stat: Journal Article,

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity [published erratum appears in J Clin Oncol 1996 Dec;14(12):3175]
Wasserheit C; Frazein A; Oratz R; Sorich J; Downey A; Hochster H; Chachoua A; Wernz J; Zeleniuch-Jacquotte A; Blum R; Speyer J
1996 Jul;14(7):1993-1999, Journal of clinical oncology
— id: 7058, year: 1996, vol: 14, page: 1993, stat: Journal Article,

Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer
Katyal S; Kramer EL; Noz ME; McCauley D; Chachoua A; Steinfeld A
1995 Dec 1;55(23 Suppl):5759s-5763s, Cancer research
— id: 12710, year: 1995, vol: 55, page: 5759s, stat: Journal Article,

Phase I study of edatrexate (EDA), doxorubicin (DOX) and G-CSF in patients with solid tumors
Wasserheit C; Chachoua A; Hochster H; Oratz R; Downey A; Farrell K; Simpson K; Blum R
1995 ;14:A1587-A1587, Proceedings (American Society of Clinical Oncology)
— id: 6023, year: 1995, vol: 14, page: A1587, stat: Journal Article,

Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor
Chachoua A; Oratz R; Hoogmoed R; Caron D; Peace D; Liebes L; Blum RH; Vilcek J
1994 Apr;15(3):217-224, Journal of immunotherapy with emphasis on tumor immunology
— id: 12982, year: 1994, vol: 15, page: 217, stat: Journal Article,

Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma
Chachoua A; Oratz R; Liebes L; Alter RS; Felice A; Peace D; Vilcek J; Blum RH
1994 Aug;16(2):132-141, Journal of immunotherapy with emphasis on tumor immunology
— id: 6590, year: 1994, vol: 16, page: 132, stat: Journal Article,

Extension of a secondary adrenal neoplasm into the inferior vena cava
Gollub MJ; Bosniak MA; Schlossberg P; Chachoua A
1994 Jul-Aug;19(4):359-360, Abdominal imaging
— id: 14630, year: 1994, vol: 19, page: 359, stat: Journal Article,

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen
Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Raphael B; Vinci RZ
1994 Mar;12(3):553-559, Journal of clinical oncology
— id: 6404, year: 1994, vol: 12, page: 553, stat: Journal Article,

Phase II trial of paclitaxel and cisplatin (DDP) in women with metastatic breast cancer
Wasserheit C; Alter R; Speyer J; Hochster H; Oratz R; Wernz J; Chachoua A; Meyers M; Sorich J; Downey A; et al
1994 ;13:A204-A204, Proceedings (American Society of Clinical Oncology)
— id: 6017, year: 1994, vol: 13, page: A204, stat: Journal Article,

Phase I study of edatrexate (EDA) and doxorubicin (DOX) in patients with solid tumors
Wasserheit C; Chachoua A; Hochster H; Farrell K; Simpson K; Blum R
1994 ;13:A1381-A1381, Proceedings (American Society of Clinical Oncology)
— id: 6016, year: 1994, vol: 13, page: A1381, stat: Journal Article,

Topotecan 21-day continuous infusion: excellent tolerance of a novel schedule
Hochster H; Speyer J; Oratz R; Meyers M; Wemz J; Chachoua A; Raphael B; Lee R; Sorich J; Taubes B; et al
1993 ;12:A356-A356, Proceedings (American Society of Clinical Oncology)
— id: 6015, year: 1993, vol: 12, page: A356, stat: Journal Article,

Kaposi's sarcoma [published erratum appears in Curr Opin Oncol 1992 Oct;4(5):999]
Cho J; Chachoua A
1992 Aug;4(4):667-673, Current opinion in oncology
— id: 13506, year: 1992, vol: 4, page: 667, stat: Journal Article,

Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma
Liebes L; Walsh CM; Chachoua A; Oratz R; Richards D; Hochster H; Peace D; Marino D; Alba S; Le Sher D; et al
1992 May 6;84(9):694-699, Journal of the National Cancer Institute
— id: 13597, year: 1992, vol: 84, page: 694, stat: Journal Article,

Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report
Beller U; Chachoua A; Speyer JL; Sorich J; Dugan M; Liebes L; Hayes R; Beckman EM
1989 Sep;34(3):407-412, Gynecologic oncology
— id: 10498, year: 1989, vol: 34, page: 407, stat: Journal Article,

Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS)
Chachoua A; Green M; Wernz J; Muggia F
1989 Nov;7(4):327-331, Investigational new drugs
— id: 10450, year: 1989, vol: 7, page: 327, stat: Journal Article,

Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndrome
Chachoua A; Green MD; Valentine F; Muggia FM
1989 ;7(3):225-229, Cancer investigation
— id: 10760, year: 1989, vol: 7, page: 225, stat: Journal Article,

Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma
Chachoua A; Krigel R; Lafleur F; Ostreicher R; Speer M; Laubenstein L; Wernz J; Rubenstein P; Zang E; Friedman-Kien A
1989 Jun;7(6):774-780, Journal of clinical oncology
— id: 10606, year: 1989, vol: 7, page: 774, stat: Journal Article,

Phase I study of the combination of alpha-2 interferon and cisplatinum
Walsh C; Speyer JL; Wernz J; Hochster H; Grossberg H; Chachoua A; Molinaro P; Meyers M; Blum RH
1989 Feb;8(1):11-15, Journal of biological response modifiers
— id: 10721, year: 1989, vol: 8, page: 11, stat: Journal Article,

Oral candidiasis and AIDS
Chaudhry AP; Chachoua A; Saltzman BR; Friedman-Kien A
1988 Jun;116(7):'129'-'136', Journal of the American Dental Association. JADA
— id: 14631, year: 1988, vol: 116, page: '129', stat: Journal Article,

Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS
Dieterich DT; Chachoua A; Lafleur F; Worrell C
1988 Jul-Aug;10 Suppl 3:S532-S537, Reviews of infectious diseases
— id: 11058, year: 1988, vol: 10 Suppl 3, page: S532, stat: Journal Article,

AZIDOTHYMIDINE GLUCURONIDATION BY HEP-G2 CELLS
LIEBES, L; HOCHSTER, H; CHACHOUA, A; JAVITT, NB
1988 APR ;36(3):A461-A461, Clinical research
— id: 41788, year: 1988, vol: 36, page: A461, stat: Journal Article,

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome
Chachoua A; Dieterich D; Krasinski K; Greene J; Laubenstein L; Wernz J; Buhles W; Koretz S
1987 Aug;107(2):133-137, Annals of internal medicine
— id: 14634, year: 1987, vol: 107, page: 133, stat: Journal Article,

Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcoma
Chachoua A; Green M; Laubenstein L; Wernz J; Muggia FM
1987 Jul-Aug;71(7-8):775-776, Cancer treatment reports
— id: 14635, year: 1987, vol: 71, page: 775, stat: Journal Article,

AIDS and occlusal trauma
Chaudhry AP; Chachoua A; Saltzman BR; Friedman-Kien A
1987 Nov;115(5):'\'563\''-'\'566\'', Journal of the American Dental Association. JADA
— id: 14633, year: 1987, vol: 115, page: '\'563\'', stat: Journal Article,

AIDS-associated Kaposi's sarcoma
Chaudhry AP; Chachoua A; Saltzman BR; Friedman-Kien AE
1987 Dec;115(6):'563'-'566', Journal of the American Dental Association. JADA
— id: 14632, year: 1987, vol: 115, page: '563', stat: Journal Article,

Immune modulating therapy in gastrointestinal cancer
Chachoua A; Green M; Muggia FM
1986 Aug;81(8):623-628, American journal of gastroenterology
— id: 14636, year: 1986, vol: 81, page: 623, stat: Journal Article,

9-1, 3 DIHYDROXY-2 PROPOXYMETHYL GUANINE IN PATIENTS WITH AIDS AND CMV INFECTIONS
CHACHOUA, A; DIETERICH, DT
1986 APR ;34(2):A514-A514, Clinical research
— id: 41400, year: 1986, vol: 34, page: A514, stat: Journal Article,

DIFLUOROMETHYLORNITHINE TREATMENT OF CRY
DIETERICH, DT; CHACHOUA, A; FAUST, M
1986 MAY ;90(5):1395-1395, Gastroenterology
— id: 41453, year: 1986, vol: 90, page: 1395, stat: Journal Article,

"TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL INFECTIONS IN AIDS PATIENTS WITH 9-(1,3-DIHYDROXY-2-PROPOXY-METHYL) GUANINE"
DIETERICH, DT; CHACHOUA, A; FAUST, M; MOSES, M
1986 MAY ;90(5):1395-1395, Gastroenterology
— id: 41454, year: 1986, vol: 90, page: 1395, stat: Journal Article,

EFLORNITHINE (DFMO) TREATMENT OF CRYPTOSPORIDIOSIS IN AIDS PATIENTS
DIETERICH, DT; CHACHOUA, A; FAUST, MJ; MOSES, M
1986 SEP ;81(9):871-871, American journal of gastroenterology
— id: 41360, year: 1986, vol: 81, page: 871, stat: Journal Article,

SUCCESSFUL TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL INFECTIONS IN AIDS PATIENTS WITH 9-(1,3-DIHYDROXY-2-PROPOXY-METHYL) GUANINE
DIETERICH, DT; CHACHOUA, A; FAUST, MJ; MOSES, M
1986 SEP ;81(9):871-871, American journal of gastroenterology
— id: 41361, year: 1986, vol: 81, page: 871, stat: Journal Article,